Matured Hop Extract

Matured hop extract (MHBA) consists of iso-α-acids from hops (Humulus lupulus) that have undergone oxidation during storage, converting to more complex bitter compounds. Found in aged beer and marketed as a supplement. NO GRADED OUTCOMES - limited research. Proposed benefits include cognitive function, anti-inflammatory effects, and metabolic health. Different from fresh hop extracts used for sleep/relaxation. Research is emerging but insufficient for recommendations.

Quick Answer

What it is

Matured hop extract (MHBA) consists of iso-α-acids from hops (Humulus lupulus) that have undergone oxidation during storage, converting to more complex bitter compounds. Found in aged beer and marketed as a supplement.

Key findings

  • Grade C: Cognitive Function
  • Grade C: Mood and Anxiety
  • Grade C: Body Fat

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts: Matured Hop Extract

Quick Facts: Matured Hop Extract

  • Best Evidence:Grade C
  • Conditions Studied:4
  • Research Outcomes:5
  • Key Effect:Age-Associated Memory Impairment and Cognitive Decline (AAMCD)
Outcomes by grade:
A0
B0
C3
D2
4 conditions · 5 outcomes

Detailed Outcomes

|
C
Cognitive Function
Three RCTs in middle-aged to older adults (n=100, n=60, n=34) found MHBA (35 mg/day) significantly improved divided attention (SDMT, p=0.045), verbal fluency (p=0.034), Stroop test performance (p=0.019), and attention/executive function after single dose. Multiple animal studies show MHBA improves hippocampus-dependent memory via vagus nerve activation and norepinephrine release, with nicotinic acetylcholine receptor involvement.
smallImproves
C
Mood and Anxiety
An RCT (n=60) found 12 weeks of MHBA (35 mg/day) significantly improved subjective fatigue and anxiety vs placebo. An RCT (n=100) found significantly lower beta-endorphin levels suggesting improved mood state. A pilot study (n=97) of non-alcoholic beer with MHBA showed improved total mood state including anxiety, depression, fatigue, and vigor after 3 weeks. Animal data show MHBA reduces LPS-induced depression-like behavior via vagus nerve-mediated norepinephrine release.
smallImproves
C
Body Fat
One large RCT (n=200) found 35 mg/day MHBA significantly reduced visceral fat area after 8 and 12 weeks and total body fat area after 12 weeks vs placebo in healthy overweight adults. Animal studies show MHBA induces thermogenesis in brown adipose tissue via sympathetic nerve activity, increasing UCP1 expression, and reduces body weight gain in diet-induced obese mice.
smallImproves
D
Neuroinflammation
In rodent models, MHBA and hop bitter acids containing beta-carbonyl moieties prevented inflammation-induced cognitive decline via the vagus nerve and noradrenergic system. MHBA reduced hippocampal IL-1beta levels in LPS-treated mice, restored dendritic spine density damaged by inflammation, and prevented neuronal loss. Effects were abolished in vagotomized mice, confirming vagus nerve dependence.
moderateImproves
D
Autonomic Nervous System Function
A randomized placebo-controlled crossover trial (n=34) found a single dose of MHBA significantly increased high-frequency heart rate variability (HF power, p=0.033) and total power (p=0.025) during cognitive tasks compared to placebo, suggesting enhanced parasympathetic (vagal) tone. This is consistent with the proposed vagus nerve activation mechanism identified in animal studies.
smallImproves

Research Citations (9)

Related Supplements

Yohimbine

2 shared conditions · 25 outcomes

Yohimbine is an alpha-2 adrenergic receptor antagonist from the Pausinystalia yohimbe tree bark. C-grade evidence for fat loss and erectile dysfunction. SIGNIFICANT SAFETY CONCERNS: Causes anxiety, elevated heart rate, and blood pressure increases - contraindicated in cardiovascular conditions, anxiety disorders, and panic disorder. Supplement quality is notoriously poor - actual yohimbine content varies widely from label claims. Effective for fat loss during fasted cardio but side effects limit use.

Spikenard

2 shared conditions · 8 outcomes

Spikenard (Jatamansi) is an Ayurvedic herb traditionally used for calming, cognitive enhancement, and neuroprotection. Similar traditional uses to Bacopa but with less research. Contains sesquiterpenes and volatile oils. NO GRADED OUTCOMES - human research is very limited. Preclinical studies show neuroprotective potential. Traditionally used for epilepsy, anxiety, and memory. The plant is endangered due to overharvesting; sustainable sourcing is a concern.

Phellodendron amurense

2 shared conditions · 6 outcomes

Phellodendron amurense is a Traditional Chinese Medicine (TCM) herb used for inflammation, infection, and bone conditions. Contains berberine (same alkaloid as in berberine supplements) and other alkaloids. Often combined with Magnolia officinalis in 'Relora' for stress/cortisol. NO GRADED OUTCOMES for the herb itself. Anti-inflammatory and antimicrobial effects in preclinical research. Limited Western clinical evidence. The berberine content may provide some of the effects attributed to berberine supplements.

Oleamide

2 shared conditions · 9 outcomes

Oleamide is an endogenous fatty acid amide produced naturally in the brain, accumulating during sleep deprivation. It induces sleep and modulates cannabinoid receptors (CB1). Structurally derived from oleic acid with nitrogen group. Animal studies show potent sleep-inducing effects via GABAergic potentiation and endocannabinoid system modulation. NO human clinical trials. Found in dark chocolate. May interact with anandamide degradation. Research limited to preclinical - cannot recommend for supplementation.

Muira puama

2 shared conditions · 6 outcomes

Muira puama is a Brazilian herb traditionally used as an aphrodisiac and nerve tonic. The nickname 'Potency Wood' reflects its traditional sexual health use, but human evidence for sexual benefits is weak. Interestingly, preliminary research suggests it may be effective as a COGNITIVE ENHANCER rather than an aphrodisiac. Contains lupeol and other triterpenoids. NO GRADED OUTCOMES - lacks quality human trials for either sexual or cognitive claims. The cognitive enhancement angle warrants more research.

L-Threonate

2 shared conditions · 5 outcomes

L-Threonate is a metabolite of vitamin C currently researched primarily as a mineral chelating agent that enhances bioavailability, especially for magnesium. Magnesium L-threonate (Magtein) is marketed for cognitive function based on claims of enhanced brain magnesium delivery. NO GRADED OUTCOMES for L-threonate itself. The compound is most notable as part of magnesium L-threonate rather than as an isolated supplement. Research suggests it may help transport magnesium across the blood-brain barrier, but evidence remains limited. Isolated L-threonate supplementation is not common.

Haskap Berry

2 shared conditions · 8 outcomes

Haskap berries (blue honeysuckle) are antioxidant-rich berries native to northern regions, called 'fruit of longevity' in Japan. Rich in anthocyanins (particularly cyanidin-3-glucoside), vitamin C, and polyphenols. NO GRADED OUTCOMES - limited human research. Anthocyanin content exceeds blueberries. May have cardiovascular, anti-inflammatory, and cognitive benefits based on similar berry research, but haskap-specific studies are lacking. Safe as a food. Available fresh, frozen, or as supplements. Emerging berry gaining research interest due to high polyphenol content.

Fish Oil

2 shared conditions · 448 outcomes

Fish oil is a mix of mostly EPA and DHA derived from fatty fish. It reduces triglycerides, but does not seem to affect the rate of cardiovascular events. It appears to reduce the symptoms of depression and improve some painful, inflammatory conditions.